Discuss titrating down to a maintenance plan Once youve achieved your desired weight, you may want to discuss reducing the dose of your weight loss treatment with your prescriber in order to maintain your weight, rather than keep reducing it
Tirzepatide 5 mg, 10 mg, and 15 mg were approved by the US FDA and the EMA in 2023 for chronic weight management [96, 97]
Zepbound cravings control is a significant benefit reported by patients
Fortunatley, telehealth companies exist to make GLP-1 meds more accessible and affordable, while also offering monthly support from qualified medical experts
Alternative treatments such as dipeptidyl peptidase-4 inhibitors and sodium glucose cotransporter- 2 inhibitors were insufficient substitutes, highlighting the essential role of continuous GLP-1 receptor agonist therapy in maintaining metabolic health